BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26215192)

  • 1. Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical Surgeon.
    Erstad DJ; Tumusiime G; Cusack JC
    Ann Surg Oncol; 2015 Oct; 22(11):3433-50. PubMed ID: 26215192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Guideline on Managing Colorectal Cancer.
    Cancer Discov; 2017 Apr; 7(4):OF2. PubMed ID: 28249840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular pathology of colorectal cancer].
    Neumann JH; Jung A; Kirchner T
    Pathologe; 2015 Mar; 36(2):137-44. PubMed ID: 25777075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal Cancer: Genetics is Changing Everything.
    Obuch JC; Ahnen DJ
    Gastroenterol Clin North Am; 2016 Sep; 45(3):459-76. PubMed ID: 27546843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Application of Targeted Next Generation Sequencing for Colorectal Cancers.
    Fontanges Q; De Mendonca R; Salmon I; Le Mercier M; D'Haene N
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized therapy for metastatic colorectal cancer.
    Silvestri A; Pin E; Huijbers A; Pellicani R; Parasido EM; Pierobon M; Petricoin E; Liotta L; Belluco C
    J Intern Med; 2013 Jul; 274(1):1-24. PubMed ID: 23527888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Examination of molecular markers used n the treatment of colon cancer].
    Domagała P; Kowalik A
    Pol J Pathol; 2014 Dec; 65(4 Suppl 1):S59-77. PubMed ID: 26165036
    [No Abstract]   [Full Text] [Related]  

  • 8. Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approach.
    Legolvan MP; Taliano RJ; Resnick MB
    Hum Pathol; 2012 Aug; 43(8):1157-68. PubMed ID: 22658275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology].
    Navarro S; Cuatrecasas M; Hernández-Losa J; Landolfi S; Musulén E; Ramón Y Cajal S; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; García-Alfonso P
    Rev Esp Patol; 2021; 54(1):41-54. PubMed ID: 33455693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of high-risk Dukes B colorectal cancer by microRNA expression profiling: a preliminary study.
    Aslam MI; Venkatesh J; Jameson JS; West K; Pringle JH; Singh B
    Colorectal Dis; 2015 Jul; 17(7):578-88. PubMed ID: 25557290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision surgery for colorectal liver metastases: Opportunities and challenges of omics-based decision making.
    Jones RP; Brudvik KW; Franklin JM; Poston GJ
    Eur J Surg Oncol; 2017 May; 43(5):875-883. PubMed ID: 28302330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in personalized colorectal cancer research.
    Kraus S; Nabiochtchikov I; Shapira S; Arber N
    Cancer Lett; 2014 May; 347(1):15-21. PubMed ID: 24491406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Biomarkers in the Personalized Treatment of Colorectal Cancer.
    Sinicrope FA; Okamoto K; Kasi PM; Kawakami H
    Clin Gastroenterol Hepatol; 2016 May; 14(5):651-8. PubMed ID: 26872400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of prognostic and predictive network of colorectal cancer based upon the 8th edition of AJCC colorectal cancer staging system].
    Yao H; Wu H; Liu Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):24-27. PubMed ID: 28105615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and Corresponding Genetic Features of Colorectal Signet Ring Cell Carcinoma.
    Tajiri K; Sudou T; Fujita F; Hisaka T; Kinugasa T; Akagi Y
    Anticancer Res; 2017 Jul; 37(7):3817-3823. PubMed ID: 28668881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biomarkers in colorectal carcinoma.
    Puerta-García E; Cañadas-Garre M; Calleja-Hernández MÁ
    Pharmacogenomics; 2015; 16(10):1189-222. PubMed ID: 26237292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
    Sakai K; Tsurutani J; Yamanaka T; Yoneshige A; Ito A; Togashi Y; De Velasco MA; Terashima M; Fujita Y; Tomida S; Tamura T; Nakagawa K; Nishio K
    PLoS One; 2015; 10(5):e0121891. PubMed ID: 25954997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection.
    Kawahara D; Fujita F; Hayashi H; Matsuyama T; Eguchi S
    Hepatogastroenterology; 2015 May; 62(139):624-8. PubMed ID: 26897942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.